Ultrasound May Better Classify Ovarian Tumors Date: November 14, 2007 ... et al. Discrimination Between Benign and Malignant Adnexal Masses by Specialist Ultrasound Examination Versus Serum CA-125.

At first blush, it seemed that screening failed again: women receiving CA-125 plus ultrasound had a 15 percent lower risk of dying from ovarian cancer than unscreened women from 2001 through 2014 ...

CA-125 is a “useful test” for ovarian cancer in primary care, especially in symptomatic women aged older than 50 years, according to a presenter at the recent National Cancer Research ...

Learn why doctors generally don't recommend a CA 125 test for ovarian ... A study of 78,216 women ages 55 to 74 randomly selected to receive either an annual CA 125 test and pelvic ultrasound ...

Ovarian cancer often goes undetected until advanced stages. Emerging tools like liquid biopsies and AI offer hope, but awareness and early symptom recognition remain critical.

In CA-125–based ovarian cancer screening trials, overall specificity and screening sensitivity of ultrasound after an elevated CA-125 exceeded 99.6% and 70%, respectively, thereby yielding a positive ...

Currently, screening is limited to a CA-125 blood test or a transvaginal ultrasound. Still, even ultrasound can be limiting in scope, notably since some ovarian cancers are first detected in the ...

Their study of 200,000 women who used both tests together caught 90 percent of ovarian cancer cases, while using ultrasound alone each year caught 75 percent.

The specificity of multimodal screening for ovarian cancer was superior to that of ultrasound screening alone; however, both screening modalities showed encouraging results, according to data from ...

Ovarian cysts are fluid-filled sacs that form on or within an ovary. Most of them are a natural part of a woman's reproductive cycle and are functional cysts that develop during ovulation. They ...